CALCR (coding calcitonin receptor) has similar gene expression patterns to MAD2L1 and RSL1D1 in tamoxifen-resistant MCF7 cells; the expression of these genes was all correlated with worse RFS in ER-positive/HER2-negative breast cancer patients who had undergone endocrine therapies only. The gene discussed is CALCR; the disease is breast carcinoma.